An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Patients With Head and Neck Cancer Receiving REGN2810 (Anti-PD-1)

Summary

This study is being conducted to compare the relationship of patient response to treatment to changes in tumor microenvironment.

Timeline

Start

2017-07-03

Primary completion

2019-06-27

Completion

2020-02-21

Drugs

Indications